|
PRKAR2A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.59280000300299E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.13250000488563E-08 |
| Normal-vs-Stage2 |
2.11310000000076E-05 |
| Normal-vs-Stage3 |
1.767420E-04 |
| Normal-vs-Stage4 |
5.3837000002499E-07 |
| Stage1-vs-Stage2 |
9.874200E-01 |
| Stage1-vs-Stage3 |
8.144200E-01 |
| Stage1-vs-Stage4 |
1.541560E-01 |
| Stage2-vs-Stage3 |
8.389800E-01 |
| Stage2-vs-Stage4 |
2.477600E-01 |
| Stage3-vs-Stage4 |
2.360800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.473099668445E-10 |
| Normal-vs-AfricanAmerican |
1.591810E-04 |
| Normal-vs-Asian |
4.839600E-04 |
| Caucasian-vs-AfricanAmerican |
6.583400E-01 |
| Caucasian-vs-Asian |
6.507000E-01 |
| AfricanAmerican-vs-Asian |
6.777200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.73516756518666E-12 |
| Normal-vs-Female |
3.705700E-02 |
| Male-vs-Female |
1.678810E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.778800E-03 |
| Normal-vs-Extreme_Weight |
1.88671300804799E-12 |
| Normal-vs-Obese |
7.93869999737851E-08 |
| Normal-vs-Extreme_Obese |
5.69139999999635E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.171200E-01 |
| Normal_Weight-vs-Obese |
8.771600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.887000E-01 |
| Extreme_Weight-vs-Obese |
2.436300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.122000E-01 |
| Obese-vs-Extreme_Obese |
6.098200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.580310E-03 |
| Normal-vs-Age(41-60Yrs) |
4.21680000028957E-07 |
| Normal-vs-Age(61-80Yrs) |
2.10479966789023E-10 |
| Normal-vs-Age(81-100Yrs) |
1.80400000004965E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.232600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.715200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.038600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.626600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.178600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.985800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.05424566246393E-12 |
| Normal-VS-Type2 PRCC |
2.020500E-03 |
| Normal-VS-KIRP CIMP |
7.208400E-02 |
| Normal-VS-Unclassified PRCC |
3.764400E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.614200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.670800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.502300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.383000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.584800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.007000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.37309996495594E-09 |
| Normal-vs-N1 |
3.93349999999737E-05 |
| Normal-vs-N2 |
3.919500E-03 |
| N0-vs-N1 |
9.242000E-01 |
| N0-vs-N2 |
9.872400E-01 |
| N1-vs-N2 |
9.584800E-01 |
|
|
